Amgen (AMGN) News Today

Van Hulzen Asset Management LLC reduced its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 13.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,860 shares of the medical research com

Texas Permanent School Fund Corp trimmed its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 19.6% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 88,891 shares of the medical research company's stock after

LSV Asset Management decreased its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 43.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 766,190 shares of the medical research company's

Great Lakes Advisors LLC lowered its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 8.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 325,093 shares of the medical research company's stock after selling 31,221 shares during the pe

Arizona State Retirement System boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 155,366 shares of the medical research c

First Business Financial Services Inc. decreased its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 79.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 919 shares of the medical research

Strategy Asset Managers LLC lifted its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 93.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,723 shares of the medical research company's stock after buying an additional 2,770

Little House Capital LLC grew its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 40.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,670 shares of the medical research company's stock afte

Amgen Inc. (NASDAQ:AMGN - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the twenty-two research firms that are currently covering the stock, MarketBeat Ratings reports. Eleven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to

Chilton Capital Management LLC increased its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 3.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 69,653 shares of the medical research company's st

Amgen Inc. (NASDAQ:AMGN - Get Free Report) was the target of a large decline in short interest during the month of August. As of August 15th, there was short interest totalling 9,240,000 shares, a decline of 5.6% from the July 31st total of 9,790,000 shares. Currently, 1.7% of the shares of the company are short sold. Based on an average daily volume of 2,170,000 shares, the short-interest ratio is currently 4.3 days.

Equitable Trust Co. grew its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 11.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,270 shares of the medical research company's stock after

NBT Bank N A NY increased its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 34.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,004 shares of the medical research company's stock after purchasing an add

Atlas Capital Advisors LLC raised its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 383.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,670 shares of the medical research company's stock after acqu

Amgen Inc. (NASDAQ:AMGN - Free Report) - Equities research analysts at Zacks Research increased their Q2 2025 earnings per share estimates for shares of Amgen in a research report issued to clients and investors on Tuesday, August 27th. Zacks Research analyst R. Department now forecasts that the

Whittier Trust Co. cut its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 5.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,733 shares of the medical research company's stock after sel

Kintegral Advisory LLC grew its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 13.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,861 shares of the medical research company's stock after acquirin

Bensler LLC boosted its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 7.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 25,232 shares of the medical research company's stock after acquiring an additional 1,640 shares during

Let’s talk about recession-resistant dividends because, if history is any guide, we are certainly “on the clock” for a slowdown if not already in one.

Callan Family Office LLC raised its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 70.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,994 shares of the medical research company's stock after pu

Eli Lilly and Co. (NYSE: LLY) is a pharmaceutical giant that's made headlines for its GLP-1/GIP weight loss drug Tirzepatide, aka Mounjaro, for Type 2 diabetes.

Easterly Investment Partners LLC lessened its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 55,613 shares of the medical research company's stock

Bank of Stockton purchased a new stake in Amgen Inc. (NASDAQ:AMGN - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 845 shares of the medical research company's stock, v

Avitas Wealth Management LLC grew its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 28.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,234 shares of the medical research company's stock after acquiring an additional